Page last updated: 2024-11-05

bromochloromethane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bromochloromethane: inhibitor of ruminal methane production [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

bromochloromethane : A halomethane that is chloromethane in which one of the hydrogens has been replaced by a bromine atom. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6333
CHEMBL ID346918
CHEBI ID17194
SCHEMBL ID49877
SCHEMBL ID435277
MeSH IDM0049587

Synonyms (57)

Synonym
fluorocarbon 1011
chlorobromomethane
monochloromonobromomethane
methane, bromochloro-
halon 1011
wln: g1e
nsc-7294
nsc7294
mil-b-4394-b
chloromethyl bromide
CHEBI:17194 ,
inchi=1/ch2brcl/c2-1-3/h1h
bromo(chloro)methane
NCGC00091237-01
hsdb 2520
un1887
ai3-15514
mono-chloro-mono-bromo-methane
brn 1730801
einecs 200-826-3
nsc 7294
ccris 817
C02661
74-97-5
methylene chlorobromide
bromochloromethane
bromochloromethane, analytical standard
bromochloromethane, contains 100 ppm bht as inhibitor, >=99.5%
bromo-chloro-methane
CHEMBL346918
bromanyl(chloranyl)methane
A838287
NCGC00091237-02
AKOS009156881
dtxcid301503
dtxsid4021503 ,
cas-74-97-5
tox21_200790
NCGC00258344-01
B0573
methylene bromochloride
unii-45wx84110g
ec 200-826-3
45wx84110g ,
bromochloromethane [un1887] [poison]
4-01-00-00074 (beilstein handbook reference)
chlorobromomethane [hsdb]
methylene bromide chloride
SCHEMBL49877
SCHEMBL435277
bromo-chloro methane
brch2cl
un 1887
ch2clbr
bromochloromethane 100 microg/ml in methanol
Q421751
AMY11119

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" First, permeability constants for dibromomethane (DBM), bromochloromethane (BCM), and methylene chloride (DCM) were calculated by using a physiologically based pharmacokinetic model for dihalomethanes to relate blood concentrations during dermal vapor exposures to the total amount of chemical which was absorbed through the skin."( A physiological pharmacokinetic model for dermal absorption of vapors in the rat.
Andersen, ME; Clewell, HJ; Jepson, GW; MacNaughton, MG; McDougal, JN, 1986
)
0.52

Dosage Studied

ExcerptRelevanceReference
" Results showed that the methanogen population in feces was reduced sixfold with no effect on the bacterial community by daily dosing with BCM."( Responses in gut microbiota and fat metabolism to a halogenated methane analogue in Sprague Dawley rats.
Luo, YH; Smidt, H; Su, Y; Zhang, LL; Zhu, WY, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
halomethaneA haloalkane that is methane in which one (or more) of the hydrogens have been replaced by a halogen atom/halogen atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency1.77830.003245.467312,589.2998AID2517
RAR-related orphan receptor gammaMus musculus (house mouse)Potency32.42230.006038.004119,952.5996AID1159521
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency20.45710.000657.913322,387.1992AID1259377
estrogen nuclear receptor alphaHomo sapiens (human)Potency57.65590.000229.305416,493.5996AID743079
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency0.00130.023723.228263.5986AID743223
Nuclear receptor ROR-gammaHomo sapiens (human)Potency74.97800.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID19825Partition coefficient (logP)1995Journal of medicinal chemistry, Feb-17, Volume: 38, Issue:4
Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications.
AID37562Induction of aneuploidy in Aspergillus nidulans.1995Journal of medicinal chemistry, Feb-17, Volume: 38, Issue:4
Molecular similarity matrices and quantitative structure-activity relationships: a case study with methodological implications.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (25.00)18.7374
1990's5 (17.86)18.2507
2000's4 (14.29)29.6817
2010's11 (39.29)24.3611
2020's1 (3.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 62.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index62.33 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.84 (4.65)
Search Engine Demand Index99.54 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (62.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (7.14%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other26 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]